Ad is loading...
FSMDX
Price
$36.81
Change
+$0.41 (+1.13%)
Updated
Nov 22 closing price
LMNOX
Price
$43.69
Change
+$0.41 (+0.95%)
Updated
Nov 22 closing price
Ad is loading...

FSMDX vs LMNOX

Header iconFSMDX vs LMNOX Comparison
Open Charts FSMDX vs LMNOXBanner chart's image
Fidelity Mid Cap Index
Price$36.81
Change+$0.41 (+1.13%)
VolumeN/A
CapitalizationN/A
Patient Opportunity I
Price$43.69
Change+$0.41 (+0.95%)
VolumeN/A
CapitalizationN/A
FSMDX vs LMNOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMDX vs. LMNOX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and LMNOX is a StrongSell.

FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 36.3B vs. LMNOX (1.62B). FSMDX pays higher dividends than LMNOX: FSMDX (1.28) vs LMNOX (0.00). FSMDX was incepted earlier than LMNOX: FSMDX (13 years) vs LMNOX (24 years). LMNOX is a more actively managed with annual turnover of: 40.00 vs. FSMDX (9.00). FSMDX has a lower initial minimum investment than LMNOX: FSMDX (0) vs LMNOX (1000000). LMNOX annual gain was more profitable for investors over the last year : 48.88 vs. FSMDX (32.77). FSMDX return over 5 years is better than : 64.70 vs. LMNOX (44.16).
FSMDXLMNOXFSMDX / LMNOX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years24 years-
Gain YTD21.58229.07874%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets36.3B1.62B2,239%
Annual Yield % from dividends1.280.00-
Returns for 1 year32.7748.8867%
Returns for 3 years14.74-4.76-310%
Returns for 5 years64.7044.16147%
Returns for 10 years124.19109.83113%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LFMD5.690.27
+4.98%
LifeMD
CULP5.090.13
+2.62%
Culp
SFM145.893.14
+2.20%
Sprouts Farmers Market
GILD89.761.13
+1.27%
Gilead Sciences
VCYT38.94-0.26
-0.66%
Veracyte